https://www.selleckchem.com/pr....oducts/idf-11774.htm
Mechanistically, LEF1-AS1 exerted its oncogenic functions through interacting with miR-1285-3p to inhibit miRNA activity. Rescue assay validated that miR-1285-3p inhibitors abrogated LEF1-AS1-silencer-caused suppression of ovarian cancer progression. Conclusion Our study revealed that LEF1-AS1 acts as a vital regulation in ovarian cancer progression. © 2020 Zhang and Ruan.Neoadjuvant hormonal therapy (NEO-HT) is a possible treatment option for breast cancer (BC) patient with estrogen receptor positive (ER+) and HER2 negative (HER2-) d
Like
Comment
Share
